Background Several studies have highlighted the incidence of Clostridioides difficile
infections (CDIs) in Taiwan and certain ribotypes have been related to severe clinical …

Background The rapid spread of C. difficile 027 has become one of the leading threats of
healthcare-associated infections wordwild. However, C. difficile 027 infections have rarely …

Abstract Introduction Several virulent Clostridium difficile clones, designated as polymerase
chain reaction (PCR) ribotypes 017, 027, or 078, are well recognized in western countries …

The emerging Clostridioides difficile strain BI/NAP1/027 has been reported to be associated
with more severe clinical symptoms and higher mortality rates, thought in part due to …

Ribotypes and toxin genotypes of clinical C. difficile isolates in Taiwan are rarely reported. A
prospective surveillance study from January 2011 to January 2013 was conducted at the …

Clostridioides difficile infection (CDI) remains a major healthcare problem worldwide,
however, little is known about CDI epidemiology in Iran. Between December 2004 and …

Introduction Clostridioides difficile (C. difficile) produces three kinds of toxins: toxin A
(enterotoxin), toxin B (cytotoxin), and C. difficile transferase (CDT), a binary toxin. Some …

Clostridioides difficile (C. difficile) is widely distributed in the intestinal tract of humans,
animals, and in the environment. It is the most common cause of diarrhea associated with …

Clostridioides difficile infection (CDI) is the most prevalent healthcare-associated infection in
the United States and carries a significant healthcare system burden. As part of an ongoing …

Background The clinical burden of Clostridioides difficile infections (CDIs) remains
substantial globally. This study aimed to investigate the ribotypes (RTs) and antimicrobial …